Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Anthony R. DePasqua

Anthony R. DePasqua

other
Ecosystem influencer

About

Anthony R. DePasqua is a medical-device executive identified publicly as the co-founder and CEO of EnClear, a company spun out from QurAlis to develop devices aimed at clearing toxic proteins from cerebrospinal fluid for ALS and other neurological diseases. BioSpace described him in December 2018 as having more than 20 years of experience in the medical device industry. He also appeared on the 2019 Neurotech Partnering agenda as a speaker representing EnClear.

Areas of interest

medical devicesbiotechneurologyALSneurodegeneration